Carlsmed (CARL) Return on Equity (2025 - 2026)
Carlsmed (CARL) reported Return on Equity of 0.0% for Q1 2026, down 1.0% on a YoY basis from 0.0% in Q1 2025, and down 18.55% quarter-over-quarter from 0.0% in Q4 2025.
Carlsmed (CARL) Return on Equity (2025 - 2026) Analysis & Trends
Carlsmed has reported Return on Equity for 2 years, with the latest figure at 0.0% in Q1 2026.
- For the quarter ending Q1 2026, Return on Equity fell 1.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (down 1.0% YoY), and the FY2025 full-year result was 0.02%, changed N/A from the prior year.
- Return on Equity for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
- The five-year high for Return on Equity was 0.0% in Q1 2025, with the low at 0.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 0.00% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 0.00% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 0.00% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -0.04% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 0.00% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 0.00% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 0.00% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 0.00% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 0.00% |
| 10 | Carlsmed | 265.54 Mn | 168.34 Mn | 12.43 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |